What happened
Shares of data analytics software company Alteryx (NYSE: AYX) jumped 20.2% in August, according to data from S&P Global Market Intelligence. For context, the S&P 500, including dividends, fell 1.6% last month.
If the name Alteryx doesn't ring a bell with you, that's probably in part because the Irvine, California-based company has only been public since March 2017. It will surely be coming across the radar of more investors, however, given its stock is one of the top-performing tech stocks of 2019. Shares are up 139% so far this year (through Sept. 6) versus the broader market's 20.5% return.
Image source: Getty Images.
So what
We can attribute Alteryx stock's strong performance last month largely to the company's July 31 release of second-quarter results that crushed Wall Street's adjusted earnings estimate. Shares popped 11.9% the following day, kicking off August with a bang.
In Q2, Alteryx's revenue soared 59% year over year to $82.0 million. Revenue growth was driven by a 34% increase in customers to 5,278 customers at the end of the quarter and a net expansion rate (annual contract value) of 133%.
As is typical for a relatively new public company, Alteryx isn't profitable on the basis of GAAP (generally accepted accounting principles). However, it is in the black from a non-GAAP, or adjusted, standpoint. It posted a GAAP net loss of $3.2 million, or $0.05 per share, an improvement from a net loss of $4.2 million, or $0.07 per share in the year-ago period. Its adjusted net income came in at $0.9 million, or $0.01 per share, up from breakeven results in the second quarter of last year, and easily beating the analyst consensus estimate of a $0.06 loss-per-share.
Now what
Alteryx's management raised the full-year 2019 revenue outlook to $370 million to $375 million, up from the previous forecast of $355 million to $360 million, and representing an increase of 47% year over year at the midpoint.
More From The Motley Fool
Beth McKenna has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Alteryx. The Motley Fool has a disclosure policy.
This article was originally published on Fool.com